According to the CDC, approximately six million Americans are living with Alzheimer's disease, but access to experimental, potentially life-saving drugs is limited. For impacted veterans, the Veterans Health Administration is looking for ways to provide that access.
Last year, Biogen, in partnership with Japanese drug company Eisai, announced that the drug called Leqembi showed promise in slowing cognitive decline in Alzaheimer's patients by 27 percent. The VHA announced it will shell out more than $26,000 annually for each veteran on Leqembi. If the FDA grants a full approval by July 6, Medicare and Medicaid services said it would immediately provide broad coverage of the drug to customers.
The experimental treatment received Accelerated Approval by the Food and Drug administration earlier this year. The specific pathway to approval had been introduced by the agency to provide speedier clearance on drugs that treat serious conditions.
Last month the Centers for Medicare and Medicaid Services declined to provide unrestricted coverage of the drug because "there is not yet evidence meeting the criteria for reconsideration."
"This standard differs from the criteria used by the FDA to assess whether medications are safe and effective. We are aware that additional publications may be forthcoming that include information relevant to the questions included in the current NCD," the agency added in its statement.
Vertical farming startup Babylon Micro-Farms recently raised $8 million in a Serie A round. Alexander Oleson, CEO and co-founder of Babylon Micro-Farms, joined Cheddar News to explain his company's mission to help businesses and communities grow their own fresh produce in a sustainable manner.
Cheddar News is highlighting companies with a focus on sustainability for Earth Month. Ashley Allen, chief sustainability officer with Oatly, joined Cheddar News to discuss her company's mission to deliver products that have a minimal environmental impact. "We want to make it easy for people to eat better and live healthier lives without recklessly taxing the planet's resources," she said.
The first image of a black hole captured in 2019 is getting a makeover. Researchers on Thursday revealed an updated version, which they made using artificial intelligence.
Some abortion clinics are fielding lots of calls from patients since a court ruling last Friday threatened the availability of a main drug used in medication abortion, mifepristone.
The Biden administration released an environmental analysis Tuesday that outlined two ways that seven Western states and tribes reliant on the over-tapped Colorado River could cut their use, but declined to publicly take a side on the best option.
